2025 Data Speaks: Why Overseas Chinese Choose China for Medical Travel? 

The tide of “returning to China for medical treatment” is rising among overseas Chinese communities, and the data reveals the core logic behind this trend — unbeatable efficiency and cost advantages that outperform the UK and Australian healthcare systems. 📊

Let’s look at the striking contrasts that matter most to patients:

✅ Waiting Time Gap: Non-urgent surgeries in Australian public hospitals take 3-12 months on average (Better Health, Victoria Government). In the UK, routine specialist appointments can take up to 6 weeks. However, in China’s top tertiary hospitals, most surgeries can be arranged within a week, with one-stop services covering examinations, operations, and post-op observation. No more waiting anxiety! 🏥

✅ Cost Advantage That’s Hard to Ignore: A dental implant costs 6,000-8,000 AUD (≈28,000-37,000 RMB) in Australia, but only 15,000-25,000 RMB in China’s first-tier cities. Cataract surgery in the UK costs around £3,000, while in China it’s only 1/3 of that. For benign tumor resection, the total cost in Australia’s private hospitals is 3,000-5,000 AUD (≈14,000-23,000 RMB), but less than 5,000 RMB in China’s tertiary hospitals. 💸

Beyond the numbers, policy support makes the journey smoother: China has optimized cross-border medical processes, canceling GP referral requirements, launching cross-border medical insurance settlement pilots in Guangdong, Zhejiang, Shanghai, and other regions, and providing exclusive services like English medical record translation and overseas medical record docking. 

At Mediversity Global, we leverage these core advantages to build seamless cross-border medical travel solutions for overseas Chinese and international patients: from personalized hospital/doctor matching (covering JCI-accredited top tertiary hospitals) to one-stop service packages including travel arrangements, post-op follow-up, and insurance coordination.